Article Listing - GENZYME GOES FOR NICHES

MOZAMBIQUE HEALTH CARE

3 February 1992

A bill allowing the establishment of a private health care sector in Mozambique for the first time since 1975 is...

CANADIAN FEARS OVER FOREIGN DATA

3 February 1992

Following on from the announcement that Canada's federal drug review and approval system is to be investigated in order to...

ADVANCE IN DIABETES RESEARCH

3 February 1992

Diabetes researchers at the University of Texas Southwestern Medical Center, Dallas, USA, have taken a first step towards the creation...

DEPRENYL TO SELL GENERIC ELDEPRYL

3 February 1992

Canadian pharmaceutical company Deprenyl Research has announced that it has received approval from the federal government to market a gen-...

CIBA-GEIGY SEEKS US SELF-MED COMPANY

3 February 1992

Ciba-Geigy's intention to move decisively to take advantage of current expansion of the self-medication market is reflected in its active...

B-M SQUIBB GIVES HEART DRUGS FREE TO POOR

3 February 1992

Bristol-Myers Squibb has announ-ced that it will give away free its cardiovascular drugs to patients who are unable to afford...

US APPROVAL FOR SB'S TRIOSTAT

3 February 1992

- SmithKline Beecham has received approval from the US Food and Drug Administration to market Triostat (tri-iodothyronine) its orphan drug...

SOLCO'S UTI PRODUCT EFFECTIVE

3 February 1992

- Swiss pharmaceutical concern Solco's immunomodulator product SolcoUrovac has been found to be 71% effective in preventing recurrent urinary tract...

NEW DIRECTOR AT INSALUD

3 February 1992

- Antolin Rodriguez Martinez has been appointed as director of Spain's national institute for health, Insalud.

NO HANSON BID FOR ICI

3 February 1992

- Speculation concerning whe-ther Lord Hanson, chairman of Hanson Plc, will make a further bid for Imperial Chemical Ind-ustries has...

Showing 94851-94860 of 95329 articles